<DOC>
	<DOCNO>NCT01217788</DOCNO>
	<brief_summary>The purpose study determine efficacy PH94B , new class therapeutic compound , administer intranasally management acute anxiety patient diagnose generalize social phobia .</brief_summary>
	<brief_title>Intranasal PH94B Management Symptoms Generalized Social Phobia</brief_title>
	<detailed_description>The essential feature generalize social phobia define Diagnostic Statistical Manual Mental Disorders , Fourth Edition ( DSM-IV ) , criterion mark persistent fear ( generally accept four ) social performance situation patient believe embarrassment could occur consequence exposure unfamiliar people and/or possible scrutiny others . The anxiety result social performance situation profound . The avoidance , fear , anxious anticipation situation interfere significantly person 's daily routine , mark impact occupational functioning and/or social life . The disorder lifetime prevalence estimate 13 % , onset typically mid-teens , diagnose slightly frequently females male . Social phobia tend chronic disorder period exacerbation , report mean duration illness approximately 20 year . There two subtypes social phobia : ( ) generalize ( discrete ) , suffer approximately 50 % social phobia patient fear avoidance extend wide range social situation , ( ii ) non-generalized , patient fear one circumscribed situation . Speaking front large group far prevalent social fear ( Lang Stein , 2001 ) . Social phobia lifetime comorbidity rate approximately 81 % psychiatric disorder ( particularly affective disorder , anxiety disorder , substance abuse disorder ) , well associate increase nonpsychiatric medical difficulty . People social phobia identify social impairment , inadequate social support , overall role impairment , specific impairment education , work , activity , well interference effort self-improvement . Unfortunately , patient , strong consensus social phobia one least commonly recognize treat mental disorder</detailed_description>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<criteria>Subject currently meet Diagnosis Social Phobia define Diagnostic Statistical Manual Mental Disorders , 4th Edition secondary another preexist psychiatric condition medical condition . Liebowitz Social Anxiety Scale ( LSAS ) score great equal 60 Screening . Score 75 great SUD scale one Performance Phase time point either Public Speaking Social Interaction Challenge Written Informed Consent prior commence study specific procedure . Women childbearingpotential must able commit consistent correct use acceptable method birth control throughout study negative serum pregnancy test result prior study drug administration . Use psychotropic medication within 30 day prior study entry . Acute chronic psychiatric disease primary diagnosis ( except Social Phobia ) time study . Note subject concurrent Generalized Anxiety Disorder ( GAD ) allow study provide primary diagnosis . Subjects history psychiatric disease schizophrenia , bipolar disorder , psychosis exclude . Presence clinical condition disease , use concomitant medication , clinical judgment Investigator could place patient undue risk , interfere study participation , confound result study . Use substances abuse within year prior study entry . Concomitant use overthecounter , prescription product , herbal preparation treatment symptom social anxiety study within 30 day prior study entry use nonstudy anxiolytic benzodiazepine study within 30 day prior study entry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Generalized Social Phobia</keyword>
	<keyword>Social Anxiety Disorder</keyword>
	<keyword>Social Phobia</keyword>
	<keyword>Phobic Disorders</keyword>
	<keyword>Phobias</keyword>
</DOC>